Sign up
Log in
  • Learning
  • Cases
  • Events
  • Faculty
  • Sign up
  • Log in
    Back to Learning

Current Clinical Data in HRPCI

This series of courses reviews the clinical evidence pathway to a Class I recommendation for Protected PCI including: a) the PROTECT studies (I, II, III) and the rationale for PROTECT IV; b) renal protection data; c) bailout data; and d) ejection fraction improvement data.

You must be logged in to view this content


Log in Sign up

Course Outline 1:09:19
Introduction to CAMP 32:23
Clinical Evidence Pathway to Class I Recommendation for High-Risk PCI 7:32
Emerging Data on Renal Protection Using Impella Support 10:34
Evaluating Bailout Impella Use in High-Risk PCI 7:03
Rationale for PROTECT IV 11:47
©2023 Abiomed, Inc. All Rights Reserved.
Safety Information
Privacy Policy
Terms of Use
Cookies Settings
Download the CAMP app